Importantly, ferroptosis inhibition in the absence of PD-1/PD-L1 blockade was also not sufficient to improve the number and function of T cells, suggesting that inhibitory checkpoints can still “brake” T-cell anti-tumor immunity even after M2 polarization has been addressed. The gene discussed is CD274; the disease is neoplasm.